Products Quotations | Page 7
Products Quotes from:
-
Advanced Quotes
We are pleased with our performance in 2005. The year was highlighted by the filing of the new drug application on NRP104, our lead compound under development, for the treatment of Attention Deficit Hyperactivity Disorder in pediatric populations. We believe that this advancement together with the progress on our other pipeline products positions us well for future growth. Looking forward, we anticipate receiving approval from the FDA on NRP104 in the second half of 2006 and making IND filings on NRP409 and NRP388, the two most advanced candidates in our preclinical pipeline, by the end of the second quarter of 2006. In addition, we plan to continue to develop NRP290, our second most advanced compound, and other drug products in our research pipeline.
-
Hard Work Quotes
We are pleased with our fourth-quarter performance and appreciate the hard work of Symbol associates. We continue to show progress in revenue and margin improvement, and are lowering our operating expenses according to plan. In 2006, our top priorities are to drive revenue growth, invest in technology innovation that will deliver new products for our customers and remain focused on enhancing operational efficiencies.
-
Broader Quotes
We are pleased to welcome Witan Investment Trust plc to the NZSX Market. NZX is keen to see a broader range of products listed on our various markets to provide greater choice for investors wanting to expand their investment horizons. Listed Investment Trusts are such products; and represent a great opportunity for investors to diversify their portfolios.